55 filings
13F-NT
Marshall Wace North America L.P.
14 Feb 24
Notice of holdings reported by another manager
5:12pm
SC 13G/A
Marshall Wace North America L.P.
14 Feb 24
Acrivon Therapeutics / Marshall Wace North America ownership change
9:51am
13F-NT
Marshall Wace North America L.P.
14 Nov 23
Notice of holdings reported by another manager
12:00am
13F-NT
Marshall Wace North America L.P.
14 Aug 23
Notice of holdings reported by another manager
4:21pm
SC 13G
NSPR
InspireMD Inc
22 May 23
InspireMD / Marshall Wace North America ownership change
4:15pm
13F-NT
jd5oiitp
15 May 23
Notice of holdings reported by another manager
3:28pm
13F-NT
vy8k0t cu
14 Feb 23
Notice of holdings reported by another manager
2:43pm
SC 13G
wwlp49z
14 Feb 23
Acrivon Therapeutics / Marshall Wace North America ownership change
9:35am
13F-NT
a0qj iykl
14 Nov 22
Notice of holdings reported by another manager
4:00pm
13F-NT
xkxf0
15 Aug 22
Notice of holdings reported by another manager
3:19pm
13F-NT
6zsrdxubdedh
16 May 22
Notice of holdings reported by another manager
11:29am
13F-NT
bnyijhb
14 Feb 22
Notice of holdings reported by another manager
12:00am
13F-HR
s8oticqww
15 Nov 21
Quarterly holdings report by institutional manager
12:00am
13F-HR/A
djnj2sed7
27 Aug 21
Quarterly holdings report by institutional manager (amended)
12:00am
13F-HR/A
irfobxcmti wtd3r
27 Aug 21
Quarterly holdings report by institutional manager (amended)
12:00am
13F-HR/A
koz2 47akzivahtxtli
26 Aug 21
Quarterly holdings report by institutional manager (amended)
4:15pm
13F-HR/A
1gk39
26 Aug 21
Quarterly holdings report by institutional manager (amended)
4:11pm
13F-HR/A
hb6m37
25 Aug 21
Quarterly holdings report by institutional manager (amended)
4:40pm
13F-HR/A
dxstn3tk4s7sc4307v9
25 Aug 21
Quarterly holdings report by institutional manager (amended)
4:35pm
13F-HR
ub5w1hu
13 Aug 21
Quarterly holdings report by institutional manager
3:49pm